PHARMACIE DE LA PORTE DE SAINT-OUEN : revenue, balance sheet and financial ratios

PHARMACIE DE LA PORTE DE SAINT-OUEN is a French company founded 12 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in PARIS (75017), this company of category PME shows in 2018 a revenue of 5.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DE LA PORTE DE SAINT-OUEN (SIREN 798415113)
Indicator 2018 2017 2016 2015 2014
Revenue 5 681 607 € 5 151 241 € 4 580 400 € 4 122 561 € 3 590 556 €
Net income 289 964 € 138 148 € 131 335 € 112 261 € 52 686 €
EBITDA 422 506 € 302 696 € 346 686 € 315 485 € 192 360 €
Net margin 5.1% 2.7% 2.9% 2.7% 1.5%

Revenue and income statement

In 2018, PHARMACIE DE LA PORTE DE SAINT-OUEN achieves revenue of 5.7 M€. Over the period 2014-2018, the company shows strong growth with a CAGR (compound annual growth rate) of +12.2%. Vs 2017, growth of +10% (5.2 M€ -> 5.7 M€). After deducting consumption (4.4 M€), gross margin stands at 1.3 M€, i.e. a rate of 23%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 423 k€, representing 7.4% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 290 k€, i.e. 5.1% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2018) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

5 681 607 €

Gross margin (2018) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

1 329 903 €

EBITDA (2018) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

422 506 €

EBIT (2018) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

426 450 €

Net income (2018) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

289 964 €

EBITDA margin (2018) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

7.4%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 161%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 23%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 5.7 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 3.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

Debt ratio (2018) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

161.24%

Financial autonomy (2018) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

23.208%

Cash flow / Revenue (2018) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

3.607%

Repayment capacity (2018) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

5.716

Asset age ratio (2018) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

52.0%

Solvency indicators evolution
PHARMACIE DE LA PORTE DE SAINT-OUEN

Sector positioning

Debt ratio
161.24 2018
2016
2017
2018
Q1: 0.0
Med: 9.68
Q3: 69.31
Average

In 2018, the debt ratio of PHARMACIE DE LA PORTE DE ... (161.24) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
23.21% 2018
2016
2017
2018
Q1: 16.73%
Med: 60.92%
Q3: 90.64%
Average

In 2018, the financial autonomy of PHARMACIE DE LA PORTE DE ... (23.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
5.72 years 2018
2016
2017
2018
Q1: 0.0 years
Med: 0.01 years
Q3: 3.23 years
Average

In 2018, the repayment capacity of PHARMACIE DE LA PORTE DE ... (5.72) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 134.81. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 7.8x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2018) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

134.808

Interest coverage (2018) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

7.763

Liquidity indicators evolution
PHARMACIE DE LA PORTE DE SAINT-OUEN

Sector positioning

Liquidity ratio
134.81 2018
2016
2017
2018
Q1: 96.2
Med: 435.9
Q3: 2617.52
Average

In 2018, the liquidity ratio of PHARMACIE DE LA PORTE DE ... (134.81) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
7.76x 2018
2016
2017
2018
Q1: -71.83x
Med: 0.0x
Q3: 0.0x
Excellent

In 2018, the interest coverage of PHARMACIE DE LA PORTE DE ... (7.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 1 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 61 days. Excellent situation: suppliers finance 60 days of the operating cycle (retail model). Inventory turnover is 29 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 40 days of revenue, i.e. 629 k€ to permanently finance. Over 2014-2018, WCR increased by +126%, requiring additional financing.

Operating WCR (2018) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

628 556 €

Customer credit (2018) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

1 j

Supplier credit (2018) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

61 j

Inventory turnover (2018) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

29 j

WCR in days of revenue (2018) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

40 j

WCR and payment terms evolution
PHARMACIE DE LA PORTE DE SAINT-OUEN

Positioning of PHARMACIE DE LA PORTE DE SAINT-OUEN in its sector

Comparison with sector Fonds de placement et entités financières similaires

Valuation estimate

Based on 170 transactions of similar company sales (all years), the value of PHARMACIE DE LA PORTE DE SAINT-OUEN is estimated at 3 248 392 € (range 2 052 060€ - 4 882 790€). With an EBITDA of 422 506€, the sector multiple of 6.8x is applied. The price/revenue ratio is 0.71x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2018
170 transactions
2052k€ 3248k€ 4882k€
3 248 392 € Range: 2 052 060€ - 4 882 790€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
422 506 € × 6.8x
Estimation 2 877 115 €
1 743 183€ - 5 070 617€
Revenue Multiple 30%
5 681 607 € × 0.71x
Estimation 4 028 782 €
2 692 707€ - 4 708 089€
Net Income Multiple 20%
289 964 € × 10.4x
Estimation 3 005 999 €
1 863 282€ - 4 675 275€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 170 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fonds de placement et entités financières similaires)

Compare PHARMACIE DE LA PORTE DE SAINT-OUEN with other companies in the same sector:

Voir toutes les statistiques du secteur Fonds de placement et entités financières similaires

Frequently asked questions about PHARMACIE DE LA PORTE DE SAINT-OUEN

What is the revenue of PHARMACIE DE LA PORTE DE SAINT-OUEN ?

The revenue of PHARMACIE DE LA PORTE DE SAINT-OUEN in 2018 is 5.7 M€.

Is PHARMACIE DE LA PORTE DE SAINT-OUEN profitable?

Yes, PHARMACIE DE LA PORTE DE SAINT-OUEN generated a net profit of 290 k€ in 2018.

Where is the headquarters of PHARMACIE DE LA PORTE DE SAINT-OUEN ?

The headquarters of PHARMACIE DE LA PORTE DE SAINT-OUEN is located in PARIS (75017), in the department Paris.

Where to find the tax return of PHARMACIE DE LA PORTE DE SAINT-OUEN ?

The tax return of PHARMACIE DE LA PORTE DE SAINT-OUEN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE LA PORTE DE SAINT-OUEN operate?

PHARMACIE DE LA PORTE DE SAINT-OUEN operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.